SiNaptic Technologies
Develops 3D-printed silicon nitride ceramic orthopedic and spinal implants, enabling complex geometries for the $1.3B foot and ankle fusion market.
- CEO / Founder
- Bryan Scheer, M.D.
- Team Size
- 11-50
- Stage
- Acquired
- Total Funding
- $1.08M
- Latest Round
- Acquired
- Key Investors
- SINTX Technologies
Technology & Products
Key Products
3D-printed silicon nitride ceramic orthopedic and spinal implants, specifically six (6) differentiated foot and ankle implant systems.
Technological Advantage
FDA-cleared interbody spinal implants and existing Master Files for regulatory streamlining; products manufactured under FDA-registered and ISO-certified quality systems.
Differentiation
Value Proposition
Provides FDA-cleared silicon nitride implants produced via 3D printing, offering a high-strength, bioactive alternative to traditional metal/PEEK implants with reduced manufacturing constraints.
How They Differentiate
Uses 3D printing instead of traditional molding for silicon nitride, allowing for complex architectures and faster iteration.
Market & Competition
Target Customers
Orthopedic and spinal surgeons and medical device distributors.
Industry Verticals
Medical
Competitors
3DCeram Sinto; XJet; Lithoz
Growth & Milestones
Growth Metrics
Acquired by SINTX Technologies in June 2025 for $750,000 in common shares; operates 7 Lithoz CeraFab S65 Medical printers; developed 6 differentiated foot and ankle implant systems; received $250,000 OEDIT Advanced Industries grant in 2024.
Major Milestones
Acquired by SINTX Technologies on June 24, 2025; FDA clearance for interbody spinal implants
Notable Customers
CTL Amedica